Funding
Turn ideas into impact
Show Me
Due: January 7, 2028
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-145
Due: January 7, 2028
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-319
Due: January 7, 2028
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-290
Due: January 7, 2028
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
US $50,000
Type
Grant
Source
Federal
Opp Number
PA-25-126
Due: January 7, 2028
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 – Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-024
Due: January 7, 2028
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
US $50,000
Type
Grant
Source
Federal
Opp Number
PA-25-302
Due: January 7, 2028
Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk
US $275,000
Type
Grant
Source
Federal
Due: January 7, 2028
NIH Research Project Grant (Parent R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PA-25-305
Due: January 7, 2028
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-300
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?